Autologous iPSC-Based Vaccines Elicit Anti-tumor Responses In Vivo

Wu and colleagues show that cancer immunity against multiple types of cancer can be achieved using an easily generalizable iPSC-based cancer vaccine. This immunity is based on overlapping epitopes between iPSCs and cancer cells and can also be achieved by reactivating the immune system as an adjuvant immunotherapy.

http://ift.tt/2Co7aVU